Authors:
Treanor, JJ
Wilkinson, BE
Masseoud, F
Hu-Primmer, J
Battaglia, R
O'Brien, D
Wolff, M
Rabinovich, G
Blackwelder, W
Katz, JM
Citation: Jj. Treanor et al., Safety and immunogenicity of a recombinant hemagglutinin vaccine for H5 influenza in humans, VACCINE, 19(13-14), 2001, pp. 1732-1737
Authors:
Pinto, LA
Blazevic, V
Anderson, SA
Venzon, DJ
Mac Trubey, C
Rowe, T
Katz, JM
Liewehr, D
Dolan, MJ
Shearer, GM
Citation: La. Pinto et al., Influenza virus-stimulated generation of anti-human immunodeficiency virus(HIV) activity after influenza vaccination in HIV-infected individuals andhealthy control subjects, J INFEC DIS, 183(7), 2001, pp. 1000-1008
Authors:
de Diego, JL
Katz, JM
Marshall, P
Gutierrez, B
Manning, JE
Nussenzweig, V
Gonzalez, J
Citation: Jl. De Diego et al., The ubiquitin-proteasome pathway plays an essential role in proteolysis during Trypanosoma cruzi remodeling, BIOCHEM, 40(4), 2001, pp. 1053-1062
Authors:
Rudenko, LG
Arden, NH
Grigorieva, E
Naychin, A
Rekstin, A
Klimov, AI
Donina, S
Desheva, J
Holman, RC
DeGuzman, A
Cox, NJ
Katz, JM
Citation: Lg. Rudenko et al., Immunogenicity and efficacy of Russian live attenuated and US inactivated influenza vaccines used alone and in combination in nursing home residents, VACCINE, 19(2-3), 2000, pp. 308-318
Citation: Jm. Katz et al., A nonionic block co-polymer adjuvant (CRL1005) enhances the immunogenicityand protective efficacy of inactivated influenza vaccine in young and agedmice, VACCINE, 18(21), 2000, pp. 2177-2187
Authors:
Tumpey, TM
Lu, XH
Morken, T
Zaki, SR
Katz, JM
Citation: Tm. Tumpey et al., Depletion of lymphocytes and diminished cytokine production in mice infected with a highly virulent influenza A (H5N1) virus isolated from humans, J VIROLOGY, 74(13), 2000, pp. 6105-6116
Authors:
Bridges, CB
Katz, JM
Seto, WH
Chan, PKS
Tsang, D
Ho, W
Mak, KH
Lim, W
Tam, JS
Clarke, M
Williams, SG
Mounts, AW
Bresee, JS
Conn, LA
Rowe, T
Hu-Primmer, J
Abernathy, RA
Lu, XH
Cox, NJ
Fukuda, K
Citation: Cb. Bridges et al., Risk of influenza A (H5N1) infection among health care workers exposed to patients with influenza A (H5N1), Hong Kong, J INFEC DIS, 181(1), 2000, pp. 344-348
Authors:
Rowe, T
Abernathy, RA
Hu-Primmer, J
Thompson, WW
Lu, XH
Lim, W
Fukuda, K
Cox, NJ
Katz, JM
Citation: T. Rowe et al., Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays, J CLIN MICR, 37(4), 1999, pp. 937-943
Authors:
Lu, XH
Tumpey, TM
Morken, T
Zaki, SR
Cox, NJ
Katz, JM
Citation: Xh. Lu et al., A mouse model for the evaluation of pathogenesis and immunity to influenzaA (H5N1) viruses isolated from humans, J VIROLOGY, 73(7), 1999, pp. 5903-5911
Authors:
Katz, JM
Lim, W
Bridges, CB
Rowe, T
Hu-Primmer, J
Lu, XH
Abernathy, RA
Clarke, M
Conn, L
Kwong, H
Lee, M
Au, G
Ho, YY
Mak, KH
Cox, NJ
Fukuda, K
Citation: Jm. Katz et al., Antibody response in individuals infected with avian influenza A (H5N1) viruses and detection of anti-H5 antibody among household and social contacts, J INFEC DIS, 180(6), 1999, pp. 1763-1770
Authors:
Mounts, AW
Kwong, H
Izurieta, HS
Ho, YY
Au, TK
Lee, M
Bridges, CB
Williams, SW
Mak, KH
Katz, JM
Thompson, WW
Cox, NJ
Fukuda, K
Citation: Aw. Mounts et al., Case-control study of risk factors for avian influenza A (H5N1) disease, Hong Kong, 1997, J INFEC DIS, 180(2), 1999, pp. 505-508